Risk Factors for Developing Peptic Ulcer Disease
Main Article Content
Abstract
Peptic ulcer disease (PUD) is predicted to affect between 0.1 and 0.3 percent of the population each year. PUD develops at a rate of roughly 1% per year in Helicobacter pylori (H. pylori) infected persons, which is 6 to 10 times higher than in uninfected people. The prevalence of PUD increases with age in both duodenal and stomach ulcers. Two factors contribute to peptic ulcer disease: H. pylori infection and the use of nonsteroidal anti-inflammatory drugs (NSAIDs). NSAIDs have also been related to an increased risk of complications from peptic ulcer disease, such as gastrointestinal bleeding, perforation, and gastric outlet obstruction.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Kuna, L., Jakab, J., Smolic, R., Raguz-Lucic, N., Vcev, A., & Smolic, M. (2019). Peptic ulcer disease: a brief review of conventional therapy and herbal treatment options. Journal of clinical medicine, 8(2), 179.
II. Padussis, J. C., & Pappas, T. N. (2010). Management of bleeding peptic ulcer disease. Gastrointestinal Bleeding: A Practical Approach to Diagnosis and Management, 39-64.
III. Chan, F. K., To, K. F., Wu, J. C., Yung, M. Y., Leung, W. K., Kwok, T., ... & Sung, J. J. (2002). Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. The Lancet, 359(9300), 9-13.
IV. Siddique, R. A. H. (2014). Prevalence of peptic ulcer disease among the patients with abdominal pain attending the department of medicine in Dhaka Medical College Hospital, Bangladesh. IOSR Journal of Dental and Medical Sciences, 13(1), 05-20.
V. Nguyen, T. N., Barkun, A. N., & Fallone, C. A. (1999). Host determinants of Helicobacter pylori infection and its clinical outcome. Helicobacter, 4(3), 185-197.
VI. Tanikawa, C., Urabe, Y., Matsuo, K., Kubo, M., Takahashi, A., Ito, H., ... & Matsuda, K. (2012). A genome-wide association study identifies two susceptibility loci for duodenal ulcer in the Japanese population. Nature genetics, 44(4), 430-434.
VII. Doyle, C. M. (2009). Reproductive hormones, immune defenses and infection: Implications for understanding etiologies of PMS, depression and breast cancer. University of Louisville.
VIII. Sambo, N., Yerima, A. M., Amaza, D. S., Bukar, A. A., & Gali, R. M. (2016). Association of ABO (H) Secretor Status with Diabetes Mellitus. IOSR Journal of Dental and Medical Sciences, 15(6), 1-5.
IX. Wu, D., Ye, X., Linhardt, R. J., Liu, X., Zhu, K., Yu, C., ... & Chen, S. (2021). Dietary pectic substances enhance gut health by its polycomponent: A review. Comprehensive Reviews in Food Science and Food Safety, 20(2), 2015-2039.
X. Ginsberg, G. G., & Lipman, T. O. (1994). NUTRITION IN GASTROINTESTINAL DISEASE: AN OVERVIEW. Practical Handbook of Nutrition in Clinical Practice, 4, 49.
XI. Katić, I., & Nešić, A. (2020). Socio-psychological effects of stress in organizations’ absenteeism problems. Work, 66(3), 689-697.
XII. Levenstein, S., Rosenstock, S., Jacobsen, R. K., & Jorgensen, T. (2015). Psychological stress increases risk for peptic ulcer, regardless of Helicobacter pylori infection or use of nonsteroidal anti-inflammatory drugs. Clinical Gastroenterology and Hepatology, 13(3), 498-506.
XIII. Knutsson, A. (2003). Health disorders of shift workers. Occupational medicine, 53(2), 103-108.
XIV. Marasco, G., Maida, M., Morreale, G. C., Licata, M., Renzulli, M., Cremon, C., ... & Barbara, G. (2021). Gastrointestinal bleeding in COVID-19 patients: a systematic review with meta-analysis. Canadian Journal of Gastroenterology and Hepatology, 2021.
XV. Richards, D. M., & Ross, W. A. (2020). Gastrointestinal bleeding in critically ill cancer patients: causes and management. Oncologic Critical Care, 857-867.